Healthcare provider profile · identity verified

Peter L Wisniewski, MD

Internal Medicine · PRINCE FREDERICK, MD · NPI 1922157593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	639	195
Amlodipine Besylate	Amlodipine Besylate	383	114
Losartan Potassium	Losartan Potassium	381	107
Levothyroxine Sodium	Levothyroxine Sodium	314	88
Lisinopril	Lisinopril	308	92
Prednisone	Prednisone	294	145
Metoprolol Succinate	Metoprolol Succinate	272	80
Pantoprazole Sodium	Pantoprazole Sodium	265	78
Alprazolam	Alprazolam	205	41
Hydrochlorothiazide	Hydrochlorothiazide	197	65
Sertraline Hcl	Sertraline Hcl	195	52
Rosuvastatin Calcium	Rosuvastatin Calcium	182	54
Albuterol Sulfate Hfa	Albuterol Sulfate	177	63
Tramadol Hcl	Tramadol Hcl	169	41
Gabapentin	Gabapentin	164	56
Azithromycin	Azithromycin	153	84
Tamsulosin Hcl	Tamsulosin Hcl	150	47
Metformin Hcl	Metformin Hcl	127	39
Meloxicam	Meloxicam	121	35
Omeprazole	Omeprazole	121	36
Furosemide	Furosemide	120	50
Montelukast Sodium	Montelukast Sodium	110	35
Eliquis	Apixaban	104	36
Allopurinol	Allopurinol	92	25
Metformin Hcl Er	Metformin Hcl	92	32
Simvastatin	Simvastatin	85	22
Ozempic	Semaglutide	84	20
Zolpidem Tartrate	Zolpidem Tartrate	82	20
Glimepiride	Glimepiride	77	23
Escitalopram Oxalate	Escitalopram Oxalate	75	27
Xarelto	Rivaroxaban	73	17
Quetiapine Fumarate	Quetiapine Fumarate	72	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	67	53
Cefdinir	Cefdinir	66	44
Clopidogrel	Clopidogrel Bisulfate	65	22
Ropinirole Hcl	Ropinirole Hcl	64	18
Synthroid	Levothyroxine Sodium	64	19
Trazodone Hcl	Trazodone Hcl	64	23
Atenolol	Atenolol	63	19
Famotidine	Famotidine	63	22
Triamcinolone Acetonide	Triamcinolone Acetonide	62	23
Ondansetron Odt	Ondansetron	61	31
Finasteride	Finasteride	60	18
Doxycycline Hyclate	Doxycycline Hyclate	59	40
Fluticasone Propionate	Fluticasone Propionate	58	16
Diazepam	Diazepam	57	suppressed
Jardiance	Empagliflozin	56	18
Mirtazapine	Mirtazapine	52	17
Donepezil Hcl	Donepezil Hcl	50	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	35
Torsemide	Torsemide	49	18
Bupropion Xl	Bupropion Hcl	48	13
Hydroxyzine Hcl	Hydroxyzine Hcl	48	15
Meclizine Hcl	Meclizine Hcl	48	18
Potassium Chloride	Potassium Chloride	47	18
Metoprolol Tartrate	Metoprolol Tartrate	45	15
Carvedilol	Carvedilol	44	15
Lorazepam	Lorazepam	44	suppressed
Clonazepam	Clonazepam	43	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	14
Ketoconazole	Ketoconazole	40	19
Ezetimibe	Ezetimibe	39	14
Levofloxacin	Levofloxacin	39	25
Memantine Hcl	Memantine Hcl	39	suppressed
Spironolactone	Spironolactone	37	12
Fluconazole	Fluconazole	35	30
Alendronate Sodium	Alendronate Sodium	34	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	13
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	15
Ipratropium Bromide	Ipratropium Bromide	29	12
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Naproxen	Naproxen	26	suppressed
Glipizide	Glipizide	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Ramipril	Ramipril	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Metronidazole	Metronidazole	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	20
Colchicine	Colchicine	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Linzess	Linaclotide	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	11
Farxiga	Dapagliflozin Propanediol	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	13
Lidocaine	Lidocaine	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Digoxin	Digoxin	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Nucala	Mepolizumab	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Rinvoq	Upadacitinib	13	suppressed
Silodosin	Silodosin	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Etodolac	Etodolac	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error